Reflux nephropathy and hypertension

Journal of Human Hypertension

Volumn 12, Issue 8, 1998, Pages 497-504

  Goonasekera, C D A ^a   Dillon, M J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Hypertension; Reflux nephropathy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN; VASOACTIVE AGENT;

ADOLESCENT; ADULT; CHILD; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENETICS; HUMAN; HYPERTENSION; INFANT; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY SCAR; KIDNEY SIZE; MALE; ONSET AGE; PLASMA RENIN ACTIVITY; PREDICTION; PROTEINURIA; REFLUX NEPHROPATHY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SODIUM TRANSPORT; VESICOURETERAL REFLUX;

EID: 0031710979     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000653     Document Type: Review

References (128)

1. Smellie JM, Normand C. Reflux nephropathy in childhood. In: Hodson J, Kincaid-Smith P (eds). Reflux Nephropathy. Masson Publishing Co Inc: New York, 1979, pp. 14-20.
2. Burger HR. A theory on the nature of transmission of congenital vesicoureteral reflux. J Urol 1972; 108: 249-254.
3. Wein AJ, Shoenberg HW. A review of 402 girls with recurrent urinary tract infection. J Urol 1972; 107: 328-334.
4. Edwards D, Normand ICS, Prescod N, Smellie JM. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. Br Med J 1977; 2: 285-288.
5. Kincaid-Smith P, Becker G. Reflux nephropathy and chronic atropic pyelonephritis: a review. J Infect Dis 1978; 138: 774-780.
6. Smellie JM et al. Vesicoureteric reflux and renal scarring. Kidney Int 1975; 8: 65-72.
7. Pylkkänen J, Vilska J, Koskimies O. The value of level diagnosis of childhood urinary tract infection in predicting renal injury. Acta Paediatr Scand 1981; 70: 879-883.
8. Smellie JM et al. Development of new renal scars: a collaborative study. Br Med 1985; 290: 1957-1960.
9. Bourchier D, Abbott GD, Maling TMJ. Radiological abnormalities in infants with urinary tract infections. Arch Dis Child 1984; 59: 620-624.
10. Smellie JM, Edwards D, Normand ICS, Prescod N. The effect of vesico-ureteric reflux on renal growth in children with urinary tract infection. Arch Dis Child 1981; 56: 593-600.
11. Winberg J. Urinary tract infections in infants and children. In: Edelman CMJ (ed). Paediatric Kidney Disease. Little, Brown and Company: Boston, 1978, pp 1121-1144.
12. Dwoskin JY, Perlmutter AD. Vesicoureteral reflux in children: A computerized review. J Urol 1973; 109: 888-890.
13. Bellinger MF, Duckett JW. Vesicoureteral reflux: A comparison of non-surgical and surgical management. In: Hodson CJ, Heptinstall RH, Winberg J (eds). Reflux Nephropathy Update. 39th edn. Karger: Basel, 1984, pp 81-93.
14. Zucchelli P, Gaggi R. Reflux Nephropathy in Adults. Nephron 1991; 57: 2-9.
15. Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 1994; 70: 111-115.
16. Ransley PG, Risdon RA. The renal papillae, intrarenal reflux and chronic pyelonephritis. In: Hodson CJ, Kincaid-Smith P (eds). Reflux Nephropathy. Masson Publishing USA Inc: New York, 1979, pp 126-133.
17. Matsumoto T et al. Increased renal scarring by bacteria with mannose-sensitive pili. Urol Res 1990; 18: 299-303.
18. Becker GJ. Reflux Nephropathy. Aust NZ J Med 1985; 15: 668-676.
19. Becker GJ, Kincaid-Smith P. Reflux nephropathy: the glomerular lesion and progression of renal failure. Pediatr Nephrol 1993; 7: 365-369.
20. Goonasekera CDA et al. 15-year follow-up of renin and blood pressure in reflux nephropathy. Lancet 1996; 347: 640-643.
21. Heale WF. Hypertension and reflux nephropathy. Aust Paediatr J 1977; 13: 56(Abstract).
22. Wallace DMA, Rothwell DL, Williams DI. The long term follow-up of surgically treated vesico-ureteric reflux. Br J Urology 1978; 50: 479-484.
23. Bailey RR. The relationship of vesico-ureteric reflux to urinary tract infection and chronic pyelonephritisreflux nephropathy. Clin Nephrol 1973; 1: 132-141.
24. Still JL, Cottom D. Severe hypertension in childhood. Arch Dis Child 1967; 42: 34-39.
25. Gill DG et al. Analysis of 100 children with severe and persistent hypertension. Arch Dis Child 1976; 51: 951-956.
26. Dillon MJ. Investigation and management of hypertension in children-A personal perspective. Pediatr Nephrol 1987; 1: 59-68.
27. Arar MY, Hogg RJ, Arant BSJ, Seikaly MG. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol 1994; 8: 186-189.
28. Zhang Y, Bailey RR. A long term follow up of adults with reflux nephropathy. N Z Med J 1995; 108: 142-144.
29. Jungers P. Reflux nephropathy and pregnancy. Balilieres Clin Obstet Gynaecol 1994; 8: 425-442.
30. Jacobson SH et al. Development of hypertension and uraemia after pyelonephritis in childhood: a 27 year follow-up. Br Med J 1989; 299: 703-706.
31. Ravat SH, Ravat HK, Shah MD, Pahlajani DB. Malignant hypertension due to reflux nephropathy in an adolescent (a case report). J Postgrad Med 1991; 37: 173-6,176 A.
32. Zucchelli P, Gaggi R. Vesicoureteral reflux and reflux nephropathy in adults. In: Colasanti G, D'Amico G (eds). Nephrology and Dialysis Updated, Karger: Basel, 1988, pp 210-219.
33. El-Khatib M, Packham DK, Becker GJ, Kincaid-Smith P. Pregnancy-related complications in women with reflux nephropathy. Clin Nephrol 1994; 41: 50-54.
34. Jungers P, Houillier P, Forget D. Reflux nephropathy and pregnancy. Baillieres Clin Obstetr & Gynaecol 1987; 1: 955-969.
35. Jungers P et al. Pregnancy in women in reflux nephropathy. Kidney Int 1996; 50: 593-599.
36. Ask-Upmark E. Über juvenile maligne Nephrosklerose und ihr Verhältnis zu Storungen in der Nierenentwicklung. Acta Pathol Microbiol Scand 1929; 6: 383-442.
37. Zezulka AV, Arkell DG, Beevers DG. The association of hypertension, the Ask-Upmark kidney and other congenital abnormalities. J Urol 1986; 135; 1000-1001.
38. Lyon RP. Renal arrest. J Urol 1973; 109: 707-710.
39. Hellstrom M et al. Renal growth after neonatal urinary tract infection. Pediatr Nephrol 1987; 1: 269-275.
40. Risdon RA, Yeung CK, Ransley PG. Reflux nephropathy in children submitted to unilateral nephrectomy: a clinicopathological study. Clin Nephrol 1993; 40: 308-314.
41. Zerin JM, Ritchey ML, Chang ACH. Incidental vesicoureteral reflux in neonates with antenatally detected hydronephrosis and other renal abnormalities. Radiology 1993; 187: 157-160.
42. Elder JS. Importance of antenatal diagnosis of vesicoureteral reflux. J Urol 1992; 148: 1750-1754.
43. 99mTechnetium-dimercaptosuccinic acid to study patterns of renal damage associated with prenatally detected vesicoureteral reflux. J Urol 1992; 148: 1229-1231.
44. Medical versus surgical treatment of primary vesicoureteral reflux: report of the International Reflux Study Committee. Pediatrics 1981; 67: 392-400.
45. Arant Jr BS, Sotelo-Avila C, Bernstein J. Segmental 'hypoplasia' of the kidney (Ask-Upmark). J Pediatr 1979; 95: 931-939.
46. Gil-Salom M et al. The Ask-Upmark kidney: a form of reflux nephropathy. Actas Urol Esp 1990; 14: 122-127.
47. Johnston JH, Mix LW. The Ask-Upmark kidney: A forum of ascending pyelonephritis? Br J Urol 1976; 48: 393-398.
48. Muchant DG, Gloor JM, Norling LL. Persistent severe hypertension in an infant with posterior urethral valves. Pediatr Nephrol 1996; 10: 764-765.
49. Arant BSJ. Vesicoureteric reflux and renal injury. Am J Kidney Dis 1991; 17: 491-511.
50. Shanon A, Feldman W. Methodologic limitations in the literature on vesicoureteral reflux: a critical review. J Pediatr 1990; 117: 171-178.
51. Orisaka S, Takamura T, Inada F, Tsuji I. Effect of vesicoureteral reflux on renal growth. J Urol 1978; 119: 25-30.
52. Becu L et al. Small kidney associated with primary vesicoureteral reflux in children. Eur Urol 1987; 305: 1-26.
53. Ingelfinger JR, Dillon MJ. Evaluation of secondary hypertension. In: Holliday MA, Barratt TM, Avner ED (eds). Pediatric Nephrology, Third edn. Williams & Wilkins: Baltimore, 1994, pp 1146-1164.
54. El-Khatib MT, Becker GJ, Kincaid-Smith PS. Reflux nephropathy and primary vesicoureteric reflux in adults. Quart J Med 1990; 284: 1241-1253.
55. Wolfish NM et al. Prevalence of hypertension in children with primary vesicoureteral reflux. J Pediatr 1993; 123: 559-563.
56. Li Z, Terdjman S, Beurton D, Cukier J. Vesico-ureteral reflux in adults. Apropos of 103 cases. J Urol Paris 1985; 91: 589-593.
57. Cotran RS. Nephrology Forum. Glomerulosclerosis in reflux nephropathy. Kidney Int 1982; 21: 528-534.
58. Bailey RR et al. Familial and genetic data in reflux nephropathy. Contrib Nephrol 1984; 39: 40-51.
59. Chapman CJ et al. Vesicoureteric reflux: segregation analysis. Am J Med Genet 1985; 20: 577-584.
60. Feather SA et al. Exclusion of key nephrogenesis genes as candidates for familial vesicoureteric reflux (VUR). J Am Soc Nephrol 1997; 8: 388A(Abstract).
61. Ozen S et al. Genetic predisposition to scar formation in reflux nephropathy: evidence for a role of angiotensin converting enzyme gene polymorphism. Pediatr Nephrol 1997; 11: C 26(Abstract).
62. Jacobson S et al. Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood - a 27-year follow-up. Pediatr Nephrol 1992; 6: 19-24.
63. Bailey RR, Lynn KL, McRae CU. Unilateral Reflux Nephropathy and Hypertension. In: Hodson CJ, Heptinstall RH, Winberg J (eds). Reflux Nephropathy Update: 1983, Karger: Basel, 1984, pp 116-125.
64. Gusmano R et al. Natural history of reflux nephropathy in children. Contrib Nephrol 1988; 61: 200-209.
65. Lindenman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 1984; 26: 861-868.
66. Kincaid-Smith PS, Bastos MG, Becker GJ. Reflux Nephropathy in the Adult. In: Hodson CJ, Heptinstall RH, Winberg J (eds). Reflux Nephropathy Update: 1983, Karger: Basel, 1984, pp 94-101.
67. Bailey RR. Long-term follow-up of infants with gross vesico-ureteric reflux. In: Hodson CJ, Heptinstall RH, Winberg J (eds). Reflux Nephropathy Update: 1983, Karger: Basel, 1984: 146-151.
68. Braren V, West JC, Boerth RC, Harmon CM. Management of children with hypertension from reflux or obstructive nephropathy. Urology 1988; 32: 228-234.
69. Smellie JM, Daman Williams CE. Vesico-ureteric reflux: recent research and its effect upon clinical practice. In: Catto GRD (ed). Urinary Tract Infection, Kluwer Academic Publishers: Dordrecht, 1989, pp 39-85.
70. Thomsen HS. Vesicoureteral reflux and reflux nephropathy. Acta Radiol Diagn 1985; 26: 3-13.
71. Ransley PG, Risdon RA. Reflux nephropathy: effect of antimicrobial therapy on the evolution of the early pyelonephritic scar. Kidney Int 1981; 20: 733-742.
72. Hodson CJ, Maling TMJ, McManamon PJ, Lewis MG. The pathogenesis of reflux nephropathy. Br J Radiol 1975; 48: 1-26.
73. Hinchliffe SA et al. Focal and segmental glomerulosclerosis in children with reflux nephropathy. Pediatr Nephrol 1994; 14: 327-338.
74. Kiprov DD, Colvin RB, McCluskey RT. Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 1982; 46: 275-281.
75. Zucchelli P et al. Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int 1983; 24: 649-655.
76. Davis BB, Thomasson D, Zenser TV. Renal disease profoundly alters cortical interstitial cells function. Kidney Int 1983; 23: 458-464.
77. Roberts JA. Pathogenesis of pyelonephritis. J Urol 1981; 129: 1102-1105.
78. Dillon MJ, Smellie JM. Peripheral plasma renin activity, hypertension and renal scarring in children. In: Hodson CJ, Heptinstall RH, Winberg J (eds). Reflux Nephropathy Update: 1983, Karger: Basel, 1984, pp 68-80.
79. Savage JM et al. Renin and blood-pressure in children with renal scarring and vesico-ureteric reflux. Lancet 1978; ii: 441-444.
80. Savage JM et al. Five year prospective study of plasma renin activity and blood pressure in patients with longstanding reflux nephropathy. Arch Dis Child 1987; 62: 678-682.
81. Jardim H et al. Prediction of blood pressure from plasma renin activity in reflux nephropathy. Arch Dis Child 1991; 66: 1213-1216.
82. Stalker HP et al. Plasma renin activity in healthy children. J Pediatr 1976; 89: 256-258.
83. Zucchelli P, Gaggi R, Zuccalà A. The natural history of reflux nephropathy. In: Oldrizzi L, Maschio G, Rugiu C (eds). The progressive nature of renal disease: Myths and Facts, Karger: Basel, 1989, pp 90-99.
84. Derkx FHM et al. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrin Metab 1986; 63: 1008-1015.
85. The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: omparisons with IUD. Task Force on Oral Contraceptives. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1989; 40: 129-145.
86. Sinaiko A, Michael A. Reflux nephropathy and hypertension: more whys and wherefores. Lancet 1996; 347: 633-634.
87. Bachmann H. Hypertension, a frequent complication in children and adolescents with reflux nephropathy. Klin Padiatr 1982; 194: 152-153.
88. Stecker JF, Jr, Read BP, Poutasse EF, Pediatric hypertension as a delayed sequela of reflux-induced chronic pyelonephritis. J Urol 1977; 118: 644-646.
89. Poutasse EF, Stecker JF, Jr, Ladaga LE, Sperber EE. Malignant hypertension in children secondary to chronic pyelonephritis: laboratory and radiologic indications for partial or total nephrectomy. Trans Am Assoc Genitourin Surg 1977; 69: 135-138.
90. Winterborn MH, France NE. Arterial changes associated with hydronephrosis in infants and children. Br J Urol 1972; 44: 96-104.
91. Garay RP, Elghozi JL, Dagher G, Meyer P. Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes. N Engl J Med 1980; 302: 769-771.
92. Aalkjaer C et al. Cell membrane sodium transport: a correlation between human resistance vessels and leucocytes. Lancet 1986; i: 649-651.
93. Hilton PJ. Cellular sodium transport in essential hypertension. N Engl J Med 1986; 314: 222-229.
94. Dahl LK, Knudsen KD, Iwai J. Humoral transmission of hypertension: evidence from parabiosis. Circulation Res 1969; 1: 21-23.
95. Haddy FJ, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci 1976; 19: 935-948.
96. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 1977; 232: C165-C173.
97. Graves SW, Brown B, Valdes R. An endogenous digoxin like substance in patients with renal impairment. Ann Intern Med 1983; 99: 604-608.
98. Goonasekera CDA, Jardim H, Shah V, Dillon MJ. Abnormalities of erythrocyte sodium transport in reflux nephropathy. J Hum Hypertens 1996; 10: 473-476.
99. Canessa M. Erythrocyte sodium-lithium counter transport: another link between essential hypertension and diabetes. Current Opinion in Nephrol & Hypertens 1994; 3: 511-517.
100. de Jong PE, van Bockel JH, de Zeeuw D. Unilateral renal parenchymal disease with contralateral renal artery stenosis of the fibrodysplasia type. Ann Intern Med 1989; 110: 437-445.
101. Kaufman J, Fay R. Renal hypertension in children. In: Johnston JH, Goodwin WE (eds). Reviews in Paediatric Urology, Excerpta Medica: Amsterdam, 1974, pp 201-240.
102. Cogan MG. Atrial natriuretic peptide. Kidney Int 1990; 37: 1148-1160.
103. Conte G et al. Physiologic role and diuretic efficacy of atrial natriuretic peptide in health and chronic renal disease. Kidney Int 1997; 59 (Suppl): S28-S32.
104. Klahr S, Purkerson ML. Eicosanoids: role in experimental renal disease. Advances in Experiment Med & Biol 1989; 259: 249-274.
105. Gothberg G. Physiology of the renomedullary depressor system. (Review). J Hypertens 1994; 12 (Suppl): S57-S64.
106. Edwards RM, Trizna W, Aiyar N. Adrenomedullin: a new peptide involved in cardiorenal homeostasis? Exp Nephrol 1997; 5: 18-22.
107. Tikkanen I, Fyhrquist F. Nitric oxide in hypertension and renal diseases. (Review). Annals of Medicine 1995; 27: 353-357.
108. Noll G, Wenzel RR, Luscher TF. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease. Mol Cell Biochem 1996; 157: 259-267.
109. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
110. Doyle AE. ACE inhibition: benefits beyond blood pressure control. Am J Med 1992; 92: 1S-2S.
111. Anderson S, Rennke HG, Brenner BM. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury. J Hypertens 1986; 4 (Suppl): S242-S244.
112. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-619.
113. Meyer TW, Anderson S, Rennke HG, Brenner BM. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987; 31: 752-759.
114. National Heart, Lung and Blood Institute, Bethesda, Maryland. Report of the second task force on blood pressure control in children. Pediatrics 1987; 79: 1-25.
115. Martinell J et al. Girls prone to urinary infections followed into adulthood. Indices of renal disease. Pediatr Nephrol 1996; 10: 139-142.
116. Javadpour N et al. Segmental renal vein renin assay and segmental nephrectomy for correction of renal hypertension. J Urol 1973; 110: 580-582.
117. Bailey RR et al. Renal vein renin concentration in the hypertension of unilateral reflux nephropathy. J Urol 1978; 120: 21-23.
118. The International Reflux Study in Children. Five-year study of medical or surgical treatment in children with severe reflux: radiological renal findings. Pediatr Nephrol 1992; 6: 223-230.
119. Birmingham Reflux Study Group. Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Br Med J Clin Res Ed 1987; 295: 237-241.
120. The Birmingham Reflux Study Group. A prospective trial of operative versus non-operative treatment of severe vesico-ureteric reflux: 2 years' observation in 96 children. Contrib Nephrol 1984; 39: 169-185.
121. Bailey RR, Lynn KL, McRae CU, Smith AH. Prospective randomised study of the effect of nephrectomy on blood pressure of patients with unilateral reflux nephropathy. In: Bailey RR (ed). Second CJ Hodson Symposium on Reflux Nephropathy, Design Printing Services: Christchurch, 1991, p 37.
122. Berg UB, Johansson SB. Age as a main determinant of renal functional damage in urinary tract infection. Arch Dis Child 1983; 58: 963-969.
123. Report of the International Reflux Study Committee. Medical versus surgical treatment of primary vesicoureteral reflux: a prospective international reflux study in children. J Urol 1981; 125: 277-283.
124. Jodal U. The natural history of bacteriuria in childhood. Infec Dis Clin N Am 1987; 1: 713-729.
125. Matsumoto T et al. Preventive effect of Ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli. Nephron 1995; 69: 65-70.
126. Stark H. Urinary tract infection in girls: the cost-effectiveness of currently recommended investigative routines. Pediatr Nephrol 1997; 11: 174-177.
127. Vesicoureteric reflux: all in the genes? Report of a meeting of physicians at the Hospital for Sick Children, Great Ormond Street, London [clinical conference]. Lancet 1996; 348: 725-728.
128. Hodson J. Reflux nephropathy. Med Clin N Am 1978; 62: 1201.